ONCY

Oncolytics Biotech
ONCY

32 hedge funds and large institutions have $2.11M invested in Oncolytics Biotech in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

less funds holding

Funds holding: →

17% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 6

Holders
32
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$201K
2
+$157K
3
+$26.4K
4
HL
HeadInvest LLC
Maine
+$23.4K
5
IAIM
International Assets Investment Management
Florida
+$16.5K

Top Sellers

1
-$597K
2
-$156K
3
-$105K
4
TRCT
Tower Research Capital (TRC)
New York
-$34.8K
5
VF
Virtu Financial
New York
-$28K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$507K
2
$479K
3
$178K
4
$161K
5
$138K
6
$104K
7
$90.1K
8
$87.1K
9
$85.3K
10
$49.2K
11
$35K
12
$32.8K
13
$31K
14
$26.4K
15
$23.4K
16
$16.1K
17
$14.7K
18
$13.5K
19
$12.2K
20
$12.1K
21
$6.86K
22
$6.52K
23
$1.89K
24
$1.3K
25
$572
1
2